PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments
PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announced the release of its latest company presentation. This comprehensive overview showcases PaxMedica’s strategic direction, recent advancements in ASD therapeutics, and its commitment to addressing unmet needs…
BioVie’s NE3107 Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for Alzheimer’s Patients in Data to be Presented at the International Conference on Alzheimer’s and Parkinson’s Diseases 2024
BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced two upcoming presentations at the International Conference on Alzheimer’s and Parkinson’s Diseases 2024 (AD/PD™…
Halozyme Announces Takeda Received European Commission Approval for HYQVIA® Co-formulated with ENHANZE® as Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced that Takeda received European Commission (EC) approval for HYQVIA® [Immune Globulin Infusion 10% (Human)] co-formulated with Halozyme’s ENHANZE® drug delivery technology as maintenance therapy in patients of all ages with chronic inflammatory demyelinating polyneuropathy (CIDP)…
INSIGHTEC MR-GUIDED FOCUSED ULTRASOUND TECHNOLOGY RECOMMENDED FOR NATIONAL COVERAGE FOR DUTCH PATIENTS LIVING WITH ESSENTIAL TREMOR
Insightec, a pioneer and global leader in focused ultrasound, has welcomed a positive recommendation report[1] from the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) to have MR-guided focused ultrasound (MRgFUS) reimbursed for people suffering from essential tremor (ET). This recommendation is a…
Rehabilitation Hospital of Columbus, a 40-bed inpatient rehabilitation hospital, now open in Georgia
Piedmont and Encompass Health (NYSE: EHC) announce the opening of the Rehabilitation Hospital of Columbus, a 40-bed inpatient rehabilitation hospital located at 8321 Veterans Parkway in Columbus, Georgia. The hospital serves patients recovering from debilitating illnesses and injuries including strokes…
Apollo Hospitals, Navi Mumbai launches Advanced Rehabilitation services with advanced technologies
Apollo Hospitals, Navi Mumbai (AHNM), the leading super-speciality quaternary care hospital, today announced the launch of the Advanced Rehabilitation services for Neurological Disorders and Critical Illness. The Advanced Rehabilitation services include the latest advanced equipment including the Lokomat for robot-assisted…
Expert Care Meets Innovation: Kamineni Hospital’s Advanced Neuro Center
Kamineni Hospital heralds a paradigm shift in neurological healthcare with the establishment of the Advanced Neuro Center, which boasts an unparalleled combination of expert care and innovative facilities. Kamineni Hospital’s Advanced Neuro Center represents the epitome of neurological care, with…
Hansa Biopharma Reaches a Crucial Milestone in Imlifidase Phase 2 Clinical Trial for Guillain-Barré Syndrome
Hansa Biopharma (Nasdaq Stockholm: HNSA), a trailblazer in the world of enzyme technology aimed at rare immunological conditions, proudly announces that enrollment for its phase 2 clinical trial of imlifidase in Guillain-Barré Syndrome (GBS) has been successfully completed. The study’s…
